Related Experiment Videos
A comparative crossover study of two long-acting bronchodilator preparations
Current Medical Research and Opinion
|January 1, 1976
Summary
Aminophylline tablets significantly improved peak expiratory flow rates (PEF) more than salbutamol tablets in patients with reversible airways obstruction. Patients also reported longer-lasting relief with aminophylline.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Reversible airways obstruction requires effective bronchodilator therapy.
- Long-acting bronchodilators are crucial for managing chronic respiratory conditions.
Purpose of the Study:
- To compare the bronchodilator effectiveness of long-acting aminophylline and salbutamol tablets.
- To assess patient-reported relief duration for both medications.
Main Methods:
- A comparative crossover study involving 18 patients with reversible airways obstruction.
- Patients received either aminophylline or salbutamol tablets for 4 weeks, then switched to the alternative.
- Peak expiratory flow rates (PEF) were measured weekly.
Main Results:
- Aminophylline tablets demonstrated a highly significant improvement in PEF compared to salbutamol tablets (p < 0.002).
- Patients reported longer-lasting symptom relief with the aminophylline preparation.
Conclusions:
- Long-acting aminophylline tablets are more effective in improving PEF than salbutamol tablets for reversible airways obstruction.
- Aminophylline offers superior duration of relief, enhancing patient quality of life.